CVS Health Corp vs ProShares UltraPro Short QQQ ETF — how do they compare? CVS Health Corp trades at $93.39 (market cap $119.58B), while ProShares UltraPro Short QQQ ETF trades at $37.36. The key difference: CVS Health Corp pays a 2.84% dividend while ProShares UltraPro Short QQQ ETF pays none, and CVS Health Corp is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals.
| CVS | SQQQ | |
|---|---|---|
Market Cap | $119.58B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $110.60 | $92.95 |
52-Week Low | $65.51 | $36.31 |
Enterprise Value | $181.93B | — |
Dividend Yield | 2.84% | — |
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →